Company Symposia
Company Symposia
The following sessions are organised by industry partners and are not part of the CME-accredited programme.
The following sessions are organised by industry partners and are not part of the CME-accredited programme.
Friday, 27 November 2026
15:00-16:00
AstraZeneca
AstraZeneca Promotional Session
15:00 - 15:20 - IMFINZI: One IO regardless of resectability in non-mNSCLC - dr. Mircea Dediu
15:20 - 15:40 - IMFINZI: One IO across the Entire SCLC Spectrum - TBD
15:40 - 16:00 - TAGRISSO: The First and Only EMA approved TKI covering the entire NSCLC EGFRm spectrum - dr. Dana Clement

16:00-16:30
AstraZeneca
AstraZeneca Educational Session
16:00 - 16:30 - Updates in Lung Cancer - dr. Michael Schenker

Saturday, 28 November 2026
10:30-11:00
Regeneron | MEDISON
Evolving Perspectives in Advanced NSCLC: Evidence Shaping Clinical Decisions
Professor Laura Mazilu, Medical Oncologist
Dr Mircea Dediu, Medical Oncologist

12:00-12:30
MSD
Keytruda, cheia mai multor posibilități pentru pacienții cu NSCLC rezecabil
Keytruda, the key for more tomorrows for patients with resectable NSCLC
Dr. Mircea Dediu
